Combination of vitamin K2 and angiotensin-converting enzyme inhibitor ameliorates cumulative recurrence of hepatocellular carcinoma.
Yoshiji H, Noguchi R, Toyohara M, Ikenaka Y, Kitade M, Kaji K, Yamazaki M, Yamao J, Mitoro A, Sawai M, Yoshida M, Fujimoto M, Tsujimoto T, Kawaratani H, Uemura M, Fukui H.
Yoshiji H, et al. Among authors: fukui h.
J Hepatol. 2009 Aug;51(2):315-21. doi: 10.1016/j.jhep.2009.04.011. Epub 2009 May 15.
J Hepatol. 2009.
PMID: 19501932
Clinical Trial.